Harm reduction in the time of COVID-19: Case study of homelessness and drug use in Dublin, Ireland-Reference-Cited by-同舟云学术

Harm reduction in the time of COVID-19: Case study of homelessness and drug use in Dublin, Ireland

Published:2021-01 Issue: Volume:87 Page:102966
ISSN:0955-3959
Container-title:International Journal of Drug Policy
language:en
Short-container-title:International Journal of Drug Policy

Author:

O'Carroll Austin,Duffin Tony,Collins John

Publisher

Elsevier BV

Subject

Health Policy,Medicine (miscellaneous)

Reference58 articles.

1. Potential implications of the COVID-19 pandemic on the homeless population;Albon;Chest,2020

2. An epidemic in the midst of a pandemic: Opioid use disorder and COVID-19;Alexander;Annals of Internal Medicine,2020

3. Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users;Baandrup;Cochrane Database of Systematic Reviews,2015

4. Addressing COVID-19 Among people experiencing homelessness: Description, adaptation, and early findings of a multiagency response in Boston;Baggett;Public Health Reports (1974),2020

5. Benzodiazepine maintenance in opiate substitution treatment: Good or bad? A retrospective primary care case-note review;Bakker;Journal of Psychopharmacology,2017

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disparities in all-cause mortality among people experiencing homelessness in Toronto, Canada during the COVID-19 pandemic: a cohort study;Frontiers in Public Health;2024-08-09

2. City-level drug policies in Portugal: the COVID-19 pandemic as an analyser of harm reduction intervention responsiveness in Porto and Lisbon;2024-07-23

3. “Just a knife wound this week, nothing too painful”: An ethnographic exploration of how primary care patients experiencing homelessness view their own health and healthcare;PLOS ONE;2024-07-09

4. Seroprevalence of SARS-CoV-2 and humoral immune responses to COVID-19 mRNA vaccines among people who use drugs - in the light of tailored mitigating strategies;Harm Reduction Journal;2024-06-19

5. Closing doors, opening windows – Adaptations and opportunities for harm reduction services during the COVID-19 pandemic in Europe;Drugs: Education, Prevention and Policy;2024-06-05